Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chlamydia Infections | 28 | 2013 | 362 | 3.380 |
Why?
|
Chlamydia trachomatis | 22 | 2013 | 238 | 3.010 |
Why?
|
Sexually Transmitted Diseases | 15 | 2011 | 628 | 1.880 |
Why?
|
Gonorrhea | 17 | 2012 | 343 | 1.360 |
Why?
|
Mass Screening | 27 | 2013 | 5422 | 1.070 |
Why?
|
Syphilis | 9 | 2012 | 241 | 1.060 |
Why?
|
Syphilis, Congenital | 8 | 2006 | 25 | 1.060 |
Why?
|
Neisseria gonorrhoeae | 6 | 2012 | 238 | 0.750 |
Why?
|
Pelvic Inflammatory Disease | 5 | 2012 | 95 | 0.750 |
Why?
|
Sexual Partners | 8 | 2012 | 753 | 0.670 |
Why?
|
Contact Tracing | 4 | 2012 | 268 | 0.640 |
Why?
|
Herpesvirus 2, Human | 3 | 2009 | 191 | 0.620 |
Why?
|
Herpes Genitalis | 2 | 2009 | 142 | 0.570 |
Why?
|
Family Planning Services | 5 | 2012 | 265 | 0.470 |
Why?
|
Pregnancy, Ectopic | 2 | 2012 | 143 | 0.450 |
Why?
|
Pregnancy Complications, Infectious | 12 | 2011 | 2125 | 0.410 |
Why?
|
Urethritis | 1 | 2012 | 24 | 0.410 |
Why?
|
Population Surveillance | 11 | 2009 | 2608 | 0.400 |
Why?
|
Sexual Behavior | 10 | 2012 | 2086 | 0.370 |
Why?
|
Prenatal Care | 11 | 2011 | 1129 | 0.350 |
Why?
|
Herpes Simplex | 3 | 2008 | 478 | 0.350 |
Why?
|
Preventive Health Services | 3 | 2006 | 570 | 0.340 |
Why?
|
Ciprofloxacin | 3 | 2012 | 312 | 0.320 |
Why?
|
Managed Care Programs | 2 | 2012 | 939 | 0.320 |
Why?
|
Prisoners | 2 | 2009 | 310 | 0.310 |
Why?
|
Infant Mortality | 6 | 2011 | 756 | 0.300 |
Why?
|
Disease Outbreaks | 4 | 2006 | 1758 | 0.290 |
Why?
|
Disease Notification | 1 | 2008 | 97 | 0.290 |
Why?
|
Antiprotozoal Agents | 1 | 2007 | 94 | 0.270 |
Why?
|
Health Plan Implementation | 1 | 2009 | 335 | 0.270 |
Why?
|
Syphilis, Latent | 1 | 2005 | 2 | 0.250 |
Why?
|
Insecticides | 1 | 2007 | 191 | 0.250 |
Why?
|
Practice Guidelines as Topic | 7 | 2011 | 7475 | 0.250 |
Why?
|
Syphilis Serodiagnosis | 1 | 2005 | 37 | 0.250 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2008 | 1348 | 0.250 |
Why?
|
United States | 47 | 2012 | 72448 | 0.240 |
Why?
|
Herpesvirus 1, Human | 2 | 2007 | 753 | 0.230 |
Why?
|
Refugees | 1 | 2012 | 598 | 0.220 |
Why?
|
Program Evaluation | 2 | 2011 | 2493 | 0.220 |
Why?
|
Anti-Infective Agents | 3 | 2012 | 981 | 0.220 |
Why?
|
Neonatal Screening | 1 | 2008 | 595 | 0.220 |
Why?
|
Adolescent | 50 | 2013 | 87809 | 0.210 |
Why?
|
Antigens, Viral | 1 | 2007 | 980 | 0.210 |
Why?
|
Treponema pallidum | 3 | 2008 | 47 | 0.200 |
Why?
|
Female | 100 | 2013 | 391246 | 0.200 |
Why?
|
Robotics | 2 | 2008 | 874 | 0.190 |
Why?
|
Thimerosal | 1 | 2001 | 15 | 0.190 |
Why?
|
Radiosurgery | 2 | 2008 | 1343 | 0.190 |
Why?
|
Respiration | 1 | 2008 | 1654 | 0.190 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2001 | 34 | 0.190 |
Why?
|
Pregnancy | 32 | 2012 | 29746 | 0.190 |
Why?
|
Maternal Health Services | 1 | 2006 | 455 | 0.190 |
Why?
|
Community Health Services | 1 | 2006 | 654 | 0.190 |
Why?
|
Fetal Death | 4 | 2011 | 434 | 0.190 |
Why?
|
Movement | 1 | 2008 | 1474 | 0.190 |
Why?
|
Anti-Bacterial Agents | 7 | 2011 | 7408 | 0.190 |
Why?
|
Humans | 129 | 2022 | 760613 | 0.180 |
Why?
|
Prevalence | 23 | 2012 | 15686 | 0.180 |
Why?
|
Age Distribution | 5 | 2013 | 2893 | 0.170 |
Why?
|
Hepatitis B Vaccines | 1 | 2001 | 186 | 0.170 |
Why?
|
Sexual Abstinence | 1 | 1999 | 16 | 0.170 |
Why?
|
Otitis Media | 2 | 2000 | 285 | 0.160 |
Why?
|
Young Adult | 17 | 2012 | 58748 | 0.160 |
Why?
|
Lung Neoplasms | 8 | 2022 | 13262 | 0.160 |
Why?
|
Models, Statistical | 2 | 2013 | 5075 | 0.150 |
Why?
|
Male | 65 | 2012 | 359718 | 0.150 |
Why?
|
Cephalosporins | 3 | 2008 | 204 | 0.150 |
Why?
|
Penicillin G Benzathine | 3 | 2011 | 25 | 0.150 |
Why?
|
Parenteral Nutrition, Total | 1 | 1998 | 303 | 0.150 |
Why?
|
Infant, Newborn, Diseases | 3 | 2001 | 592 | 0.140 |
Why?
|
Clinical Laboratory Techniques | 1 | 2002 | 749 | 0.140 |
Why?
|
Infant, Newborn | 20 | 2011 | 26179 | 0.140 |
Why?
|
Condoms | 4 | 2009 | 315 | 0.140 |
Why?
|
Vaginal Smears | 1 | 2000 | 495 | 0.140 |
Why?
|
Adult | 59 | 2013 | 220007 | 0.140 |
Why?
|
Pregnancy Complications | 5 | 2010 | 2942 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2022 | 5251 | 0.130 |
Why?
|
Genital Diseases, Female | 2 | 2010 | 191 | 0.130 |
Why?
|
Gestational Age | 7 | 2011 | 3564 | 0.130 |
Why?
|
Alcoholism | 4 | 1999 | 1961 | 0.130 |
Why?
|
Infertility | 2 | 2012 | 655 | 0.120 |
Why?
|
Vaginosis, Bacterial | 2 | 2011 | 142 | 0.120 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 1996 | 662 | 0.120 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1996 | 227 | 0.120 |
Why?
|
Ambulatory Care Facilities | 3 | 2011 | 926 | 0.120 |
Why?
|
Public Health | 5 | 2013 | 2653 | 0.110 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2014 | 93 | 0.110 |
Why?
|
Idaho | 2 | 2012 | 16 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 1998 | 526 | 0.110 |
Why?
|
Azithromycin | 2 | 2006 | 200 | 0.110 |
Why?
|
Healthcare Disparities | 1 | 2008 | 3386 | 0.110 |
Why?
|
Drug Resistance, Microbial | 2 | 2008 | 856 | 0.100 |
Why?
|
Sentinel Surveillance | 3 | 2013 | 293 | 0.100 |
Why?
|
Washington | 2 | 2012 | 312 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 3 | 2012 | 1055 | 0.100 |
Why?
|
Colonic Diseases, Functional | 2 | 2002 | 39 | 0.100 |
Why?
|
Birth Weight | 4 | 2002 | 2097 | 0.100 |
Why?
|
Matrix Metalloproteinase 8 | 2 | 2001 | 56 | 0.100 |
Why?
|
Obstetric Labor, Premature | 3 | 2001 | 274 | 0.100 |
Why?
|
Seroepidemiologic Studies | 3 | 2008 | 394 | 0.100 |
Why?
|
Minnesota | 1 | 2012 | 340 | 0.100 |
Why?
|
Recurrence | 5 | 2010 | 8483 | 0.100 |
Why?
|
Chlamydia | 1 | 2011 | 33 | 0.090 |
Why?
|
Nutrition Surveys | 4 | 2012 | 1725 | 0.090 |
Why?
|
HIV Infections | 6 | 2012 | 17165 | 0.090 |
Why?
|
Anus Neoplasms | 1 | 1995 | 329 | 0.090 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2001 | 137 | 0.090 |
Why?
|
Evidence-Based Medicine | 3 | 2012 | 3696 | 0.090 |
Why?
|
Alcohol Drinking | 6 | 2000 | 4013 | 0.090 |
Why?
|
Urban Population | 3 | 2006 | 2022 | 0.080 |
Why?
|
Homosexuality, Male | 3 | 2012 | 1273 | 0.080 |
Why?
|
Amniotic Fluid | 2 | 2001 | 378 | 0.080 |
Why?
|
Risk-Taking | 2 | 2009 | 998 | 0.080 |
Why?
|
Predictive Value of Tests | 6 | 2012 | 15286 | 0.080 |
Why?
|
Safe Sex | 1 | 2009 | 139 | 0.080 |
Why?
|
Lung | 3 | 2009 | 9994 | 0.080 |
Why?
|
Philadelphia | 1 | 2009 | 265 | 0.080 |
Why?
|
Reproductive Health Services | 1 | 2009 | 87 | 0.080 |
Why?
|
International Classification of Diseases | 2 | 2011 | 894 | 0.080 |
Why?
|
Urachal Cyst | 1 | 1988 | 7 | 0.080 |
Why?
|
Medical Audit | 2 | 2011 | 453 | 0.080 |
Why?
|
Urachus | 1 | 1988 | 18 | 0.080 |
Why?
|
Immunoenzyme Techniques | 2 | 2002 | 1705 | 0.080 |
Why?
|
Infant, Low Birth Weight | 3 | 1987 | 859 | 0.080 |
Why?
|
Guidelines as Topic | 2 | 2012 | 1392 | 0.080 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2014 | 801 | 0.080 |
Why?
|
Stillbirth | 1 | 2011 | 367 | 0.070 |
Why?
|
Monocytes | 3 | 2002 | 2575 | 0.070 |
Why?
|
Hospitals, Municipal | 1 | 1987 | 19 | 0.070 |
Why?
|
Case Management | 1 | 2009 | 272 | 0.070 |
Why?
|
Trichomonas Vaginitis | 1 | 2007 | 33 | 0.070 |
Why?
|
Female Urogenital Diseases | 2 | 2011 | 57 | 0.070 |
Why?
|
Pregnancy in Adolescence | 1 | 2009 | 162 | 0.070 |
Why?
|
Prisons | 1 | 2009 | 170 | 0.070 |
Why?
|
Exhalation | 1 | 2008 | 181 | 0.070 |
Why?
|
Trichomonas vaginalis | 1 | 2007 | 70 | 0.070 |
Why?
|
Financing, Government | 1 | 2011 | 472 | 0.070 |
Why?
|
Puerperal Infection | 1 | 1987 | 44 | 0.070 |
Why?
|
Office Visits | 2 | 2009 | 597 | 0.070 |
Why?
|
Twins, Dizygotic | 1 | 1987 | 236 | 0.070 |
Why?
|
Mycoplasma Infections | 1 | 1987 | 120 | 0.070 |
Why?
|
Tennessee | 1 | 2006 | 119 | 0.070 |
Why?
|
Indiana | 1 | 2006 | 93 | 0.070 |
Why?
|
Object Attachment | 1 | 2009 | 324 | 0.070 |
Why?
|
Abdominal Neoplasms | 1 | 2008 | 286 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2011 | 14661 | 0.070 |
Why?
|
Southeastern United States | 1 | 2006 | 90 | 0.070 |
Why?
|
Electromagnetic Phenomena | 1 | 2007 | 161 | 0.070 |
Why?
|
Hospitals, Special | 1 | 2006 | 90 | 0.070 |
Why?
|
Risk Factors | 23 | 2012 | 74333 | 0.070 |
Why?
|
Electronic Mail | 1 | 2008 | 213 | 0.070 |
Why?
|
Specialization | 2 | 2009 | 778 | 0.070 |
Why?
|
Carboplatin | 2 | 2006 | 789 | 0.070 |
Why?
|
Radiotherapy, Conformal | 1 | 2009 | 549 | 0.070 |
Why?
|
Twins | 1 | 1987 | 339 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 1995 | 1152 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2011 | 1180 | 0.060 |
Why?
|
Hospitals, Public | 1 | 1987 | 201 | 0.060 |
Why?
|
Medical Records | 3 | 2008 | 1407 | 0.060 |
Why?
|
Private Practice | 1 | 2006 | 152 | 0.060 |
Why?
|
Brain Diseases | 1 | 1994 | 1540 | 0.060 |
Why?
|
Infertility, Male | 1 | 2008 | 396 | 0.060 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 2005 | 29 | 0.060 |
Why?
|
Bisexuality | 1 | 2007 | 274 | 0.060 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2005 | 60 | 0.060 |
Why?
|
Middle Aged | 27 | 2012 | 220359 | 0.060 |
Why?
|
Health Services | 1 | 2009 | 753 | 0.060 |
Why?
|
Socioeconomic Factors | 4 | 2008 | 7805 | 0.060 |
Why?
|
Gold | 1 | 2008 | 484 | 0.060 |
Why?
|
Sepsis | 1 | 1998 | 2592 | 0.060 |
Why?
|
Telephone | 1 | 2008 | 624 | 0.060 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2008 | 497 | 0.060 |
Why?
|
Sex Distribution | 1 | 2009 | 2294 | 0.060 |
Why?
|
Puerto Rico | 1 | 2005 | 373 | 0.060 |
Why?
|
Northwestern United States | 3 | 2013 | 20 | 0.060 |
Why?
|
Chlamydiaceae Infections | 1 | 2003 | 2 | 0.060 |
Why?
|
Attitude | 1 | 2008 | 777 | 0.060 |
Why?
|
Guideline Adherence | 2 | 2006 | 2283 | 0.060 |
Why?
|
California | 2 | 2005 | 1416 | 0.050 |
Why?
|
Sex Offenses | 2 | 2009 | 351 | 0.050 |
Why?
|
Fever | 2 | 2001 | 1617 | 0.050 |
Why?
|
Delivery, Obstetric | 4 | 2001 | 932 | 0.050 |
Why?
|
Maternal Age | 2 | 2002 | 807 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2001 | 15840 | 0.050 |
Why?
|
Cervix Uteri | 2 | 2002 | 582 | 0.050 |
Why?
|
Urethral Diseases | 1 | 2002 | 53 | 0.050 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 416 | 0.050 |
Why?
|
Male Urogenital Diseases | 1 | 2002 | 48 | 0.050 |
Why?
|
Infertility, Female | 1 | 2008 | 759 | 0.050 |
Why?
|
Thailand | 1 | 2003 | 289 | 0.050 |
Why?
|
Residence Characteristics | 2 | 2011 | 2061 | 0.050 |
Why?
|
Serotonin Antagonists | 1 | 2002 | 144 | 0.050 |
Why?
|
Extraembryonic Membranes | 1 | 2001 | 38 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5397 | 0.050 |
Why?
|
Pharyngeal Diseases | 1 | 2002 | 134 | 0.050 |
Why?
|
Bronchoscopy | 1 | 2007 | 911 | 0.050 |
Why?
|
Colorado | 2 | 2000 | 164 | 0.050 |
Why?
|
Hospitals, Maternity | 1 | 2001 | 33 | 0.050 |
Why?
|
Rectal Diseases | 1 | 2002 | 144 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2008 | 1273 | 0.050 |
Why?
|
Thienamycins | 1 | 2000 | 29 | 0.050 |
Why?
|
Urine | 1 | 2002 | 363 | 0.050 |
Why?
|
Age Factors | 8 | 2009 | 18413 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 1 | 2002 | 1304 | 0.050 |
Why?
|
Antibodies, Bacterial | 2 | 2008 | 1468 | 0.050 |
Why?
|
Carbazoles | 1 | 2022 | 220 | 0.050 |
Why?
|
Texas | 3 | 2009 | 401 | 0.050 |
Why?
|
Ceftazidime | 1 | 2000 | 57 | 0.050 |
Why?
|
DNA, Bacterial | 2 | 2003 | 1456 | 0.050 |
Why?
|
Epidemiologic Research Design | 1 | 2004 | 368 | 0.050 |
Why?
|
Colon, Sigmoid | 1 | 2001 | 124 | 0.050 |
Why?
|
Pneumonia | 2 | 2009 | 2131 | 0.050 |
Why?
|
Urethra | 1 | 2002 | 406 | 0.040 |
Why?
|
Attitude of Health Personnel | 2 | 2009 | 3865 | 0.040 |
Why?
|
Carbolines | 1 | 2002 | 288 | 0.040 |
Why?
|
Breast | 1 | 2009 | 1963 | 0.040 |
Why?
|
Cross-Sectional Studies | 8 | 2012 | 25941 | 0.040 |
Why?
|
Epidemiologic Methods | 2 | 2004 | 1343 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2000 | 66 | 0.040 |
Why?
|
Abortion, Spontaneous | 1 | 1985 | 530 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2002 | 2907 | 0.040 |
Why?
|
Treatment Failure | 2 | 2005 | 2647 | 0.040 |
Why?
|
Physicians | 2 | 2009 | 4591 | 0.040 |
Why?
|
Growth | 1 | 2002 | 365 | 0.040 |
Why?
|
Postoperative Care | 1 | 2006 | 1479 | 0.040 |
Why?
|
Polymerase Chain Reaction | 4 | 2007 | 6065 | 0.040 |
Why?
|
Information Systems | 1 | 2002 | 398 | 0.040 |
Why?
|
Women's Health | 1 | 2009 | 2056 | 0.040 |
Why?
|
Granulocytes | 1 | 2001 | 551 | 0.040 |
Why?
|
Logistic Models | 7 | 2008 | 13312 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2012 | 20080 | 0.040 |
Why?
|
Erythromycin | 2 | 1997 | 117 | 0.040 |
Why?
|
Surgery, Computer-Assisted | 1 | 2007 | 1007 | 0.040 |
Why?
|
Premature Birth | 1 | 2011 | 1770 | 0.040 |
Why?
|
Mexican Americans | 2 | 2012 | 165 | 0.040 |
Why?
|
DNA Probes | 1 | 2000 | 551 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2011 | 10343 | 0.040 |
Why?
|
Paclitaxel | 1 | 2006 | 1737 | 0.040 |
Why?
|
Statistics as Topic | 1 | 1985 | 2362 | 0.040 |
Why?
|
Fetal Diseases | 1 | 2004 | 911 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2009 | 2782 | 0.040 |
Why?
|
Anesthetics, General | 1 | 2000 | 151 | 0.040 |
Why?
|
Zinc | 1 | 2002 | 689 | 0.040 |
Why?
|
Magnesium | 1 | 2002 | 810 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2009 | 3142 | 0.040 |
Why?
|
Sulfisoxazole | 1 | 1997 | 8 | 0.040 |
Why?
|
Infant | 5 | 2008 | 36053 | 0.040 |
Why?
|
Specimen Handling | 1 | 2002 | 707 | 0.040 |
Why?
|
Retrospective Studies | 8 | 2012 | 80345 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2002 | 509 | 0.040 |
Why?
|
Infant, Premature | 1 | 1987 | 2092 | 0.040 |
Why?
|
Personality Inventory | 1 | 2000 | 1018 | 0.040 |
Why?
|
Brain | 4 | 2002 | 26951 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 6965 | 0.040 |
Why?
|
Central Nervous System Depressants | 1 | 1998 | 164 | 0.030 |
Why?
|
Fetal Organ Maturity | 1 | 1996 | 83 | 0.030 |
Why?
|
Amoxicillin | 1 | 1997 | 180 | 0.030 |
Why?
|
Meningitis, Cryptococcal | 1 | 1996 | 66 | 0.030 |
Why?
|
Fluconazole | 1 | 1996 | 155 | 0.030 |
Why?
|
Health Policy | 1 | 2008 | 2677 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4542 | 0.030 |
Why?
|
Child | 7 | 2011 | 79799 | 0.030 |
Why?
|
Cryptococcus neoformans | 1 | 1996 | 121 | 0.030 |
Why?
|
Incidence | 4 | 2008 | 21391 | 0.030 |
Why?
|
Cohort Studies | 6 | 2011 | 41337 | 0.030 |
Why?
|
Rhodamine 123 | 1 | 1995 | 37 | 0.030 |
Why?
|
Carcinoma | 1 | 2007 | 2331 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3164 | 0.030 |
Why?
|
Hepatitis B | 1 | 2001 | 701 | 0.030 |
Why?
|
Uremia | 2 | 2002 | 201 | 0.030 |
Why?
|
Prospective Studies | 11 | 2011 | 54306 | 0.030 |
Why?
|
Povidone | 1 | 1995 | 30 | 0.030 |
Why?
|
Bone Marrow Purging | 1 | 1995 | 108 | 0.030 |
Why?
|
Neutropenia | 1 | 2000 | 884 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 1995 | 299 | 0.030 |
Why?
|
Neoplasm Staging | 5 | 2006 | 11152 | 0.030 |
Why?
|
Rectum | 2 | 2002 | 895 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1613 | 0.030 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2821 | 0.030 |
Why?
|
Registries | 1 | 2011 | 8458 | 0.030 |
Why?
|
Health Promotion | 1 | 2006 | 2207 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2000 | 558 | 0.030 |
Why?
|
Silicon Dioxide | 1 | 1995 | 216 | 0.030 |
Why?
|
Patient Compliance | 2 | 2006 | 2688 | 0.030 |
Why?
|
Linear Models | 2 | 2001 | 5877 | 0.030 |
Why?
|
Psychology | 2 | 2011 | 355 | 0.030 |
Why?
|
Piperidines | 1 | 2022 | 1650 | 0.030 |
Why?
|
New Jersey | 2 | 2000 | 291 | 0.030 |
Why?
|
Atrial Natriuretic Factor | 1 | 1995 | 350 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2002 | 1204 | 0.030 |
Why?
|
Adolescent Health Services | 2 | 2009 | 218 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2001 | 1403 | 0.030 |
Why?
|
Double-Blind Method | 4 | 2002 | 12427 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2000 | 1001 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2002 | 1801 | 0.030 |
Why?
|
Social Support | 2 | 1999 | 2145 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2013 | 3985 | 0.030 |
Why?
|
Boston | 3 | 2000 | 9278 | 0.030 |
Why?
|
Anal Canal | 1 | 1995 | 372 | 0.020 |
Why?
|
Missouri | 1 | 2011 | 114 | 0.020 |
Why?
|
Drug Combinations | 1 | 1997 | 2025 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 1994 | 485 | 0.020 |
Why?
|
Shock, Septic | 1 | 1998 | 760 | 0.020 |
Why?
|
Ethanol | 1 | 1998 | 1323 | 0.020 |
Why?
|
Evoked Potentials, Visual | 1 | 1994 | 415 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2001 | 1229 | 0.020 |
Why?
|
Multivariate Analysis | 4 | 2007 | 12159 | 0.020 |
Why?
|
Drug Utilization | 1 | 1997 | 1195 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 13982 | 0.020 |
Why?
|
Abortion, Induced | 2 | 2009 | 460 | 0.020 |
Why?
|
Patient Selection | 2 | 2007 | 4279 | 0.020 |
Why?
|
Osmolar Concentration | 2 | 2001 | 660 | 0.020 |
Why?
|
Health Services Research | 2 | 2014 | 1810 | 0.020 |
Why?
|
Heterosexuality | 1 | 2012 | 294 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2002 | 2470 | 0.020 |
Why?
|
Cyclosporins | 1 | 1990 | 216 | 0.020 |
Why?
|
Regression Analysis | 2 | 1996 | 6359 | 0.020 |
Why?
|
Sodium | 1 | 1995 | 1594 | 0.020 |
Why?
|
Sex Education | 1 | 2009 | 92 | 0.020 |
Why?
|
Women's Health Services | 1 | 2009 | 89 | 0.020 |
Why?
|
Drug Costs | 1 | 1997 | 1185 | 0.020 |
Why?
|
Sexuality | 1 | 2010 | 170 | 0.020 |
Why?
|
New York | 1 | 2011 | 875 | 0.020 |
Why?
|
Interviews as Topic | 2 | 2007 | 2659 | 0.020 |
Why?
|
Health Status Disparities | 2 | 2012 | 1829 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2014 | 664 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2006 | 8552 | 0.020 |
Why?
|
Tomography, Emission-Computed | 2 | 2002 | 1121 | 0.020 |
Why?
|
Calcium | 1 | 2002 | 5725 | 0.020 |
Why?
|
Health Care Costs | 2 | 2014 | 3258 | 0.020 |
Why?
|
Time Factors | 7 | 2009 | 40139 | 0.020 |
Why?
|
Follow-Up Studies | 6 | 2011 | 39262 | 0.020 |
Why?
|
Penicillins | 1 | 1991 | 407 | 0.020 |
Why?
|
Nociceptors | 2 | 2002 | 457 | 0.020 |
Why?
|
Medicaid | 2 | 2000 | 2815 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 1995 | 1646 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 1995 | 2414 | 0.020 |
Why?
|
Health Expenditures | 1 | 2000 | 2362 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 389 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2000 | 3448 | 0.020 |
Why?
|
Ureaplasma | 1 | 1987 | 60 | 0.020 |
Why?
|
Georgia | 1 | 1987 | 190 | 0.020 |
Why?
|
Endometritis | 1 | 1987 | 49 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1500 | 0.020 |
Why?
|
Alaska | 2 | 1997 | 68 | 0.020 |
Why?
|
Urinary Bladder Diseases | 1 | 1988 | 169 | 0.020 |
Why?
|
Mycoplasma | 1 | 1987 | 138 | 0.020 |
Why?
|
Acute Disease | 1 | 1997 | 7268 | 0.020 |
Why?
|
Neoplasms | 2 | 2014 | 22075 | 0.020 |
Why?
|
Diverticulum | 1 | 1988 | 137 | 0.020 |
Why?
|
Urography | 1 | 1988 | 312 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4356 | 0.020 |
Why?
|
Developed Countries | 1 | 2009 | 442 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1548 | 0.020 |
Why?
|
Travel | 1 | 2012 | 785 | 0.020 |
Why?
|
Marriage | 2 | 1985 | 350 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8055 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5640 | 0.020 |
Why?
|
Aged | 13 | 2007 | 169143 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2012 | 1949 | 0.020 |
Why?
|
Selection Bias | 1 | 2007 | 358 | 0.020 |
Why?
|
Self Concept | 1 | 2011 | 1039 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1995 | 1489 | 0.020 |
Why?
|
Animals | 6 | 2010 | 167960 | 0.020 |
Why?
|
District of Columbia | 1 | 2005 | 160 | 0.020 |
Why?
|
Risk | 2 | 1987 | 9632 | 0.020 |
Why?
|
Risk Assessment | 3 | 2002 | 24102 | 0.010 |
Why?
|
Quinolones | 1 | 2008 | 377 | 0.010 |
Why?
|
Marital Status | 2 | 1997 | 433 | 0.010 |
Why?
|
Thoracotomy | 1 | 2006 | 363 | 0.010 |
Why?
|
Immunoassay | 1 | 2008 | 746 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1994 | 6498 | 0.010 |
Why?
|
Government Regulation | 1 | 2008 | 525 | 0.010 |
Why?
|
Child Health Services | 1 | 2009 | 644 | 0.010 |
Why?
|
Intrauterine Devices | 1 | 1985 | 114 | 0.010 |
Why?
|
Cell Division | 2 | 2002 | 4463 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 1999 | 4491 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2005 | 8985 | 0.010 |
Why?
|
Psychiatry | 1 | 1996 | 1689 | 0.010 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 495 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13627 | 0.010 |
Why?
|
Ligase Chain Reaction | 1 | 2003 | 8 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1987 | 1351 | 0.010 |
Why?
|
Analysis of Variance | 3 | 1999 | 6238 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2009 | 21029 | 0.010 |
Why?
|
Primary Prevention | 1 | 2010 | 1207 | 0.010 |
Why?
|
Alleles | 1 | 1994 | 6900 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1650 | 0.010 |
Why?
|
Aged, 80 and over | 6 | 2007 | 58980 | 0.010 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2002 | 44 | 0.010 |
Why?
|
Sex Factors | 3 | 2000 | 10546 | 0.010 |
Why?
|
Program Development | 1 | 2008 | 1297 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11713 | 0.010 |
Why?
|
Vagina | 1 | 2007 | 837 | 0.010 |
Why?
|
Behavior Therapy | 1 | 2007 | 868 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2002 | 201 | 0.010 |
Why?
|
Amniocentesis | 1 | 2001 | 115 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8803 | 0.010 |
Why?
|
Cerebrovascular Circulation | 2 | 2002 | 2733 | 0.010 |
Why?
|
Receptors, Serotonin | 1 | 2002 | 208 | 0.010 |
Why?
|
Proportional Hazards Models | 3 | 2001 | 12531 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1722 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1998 | 9185 | 0.010 |
Why?
|
Quality of Life | 2 | 1999 | 13308 | 0.010 |
Why?
|
Ion Transport | 1 | 2002 | 318 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2009 | 1957 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2002 | 518 | 0.010 |
Why?
|
Attitude to Health | 1 | 2009 | 2029 | 0.010 |
Why?
|
Treatment Outcome | 6 | 2008 | 64981 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2003 | 877 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1999 | 9278 | 0.010 |
Why?
|
Depression, Chemical | 1 | 2000 | 185 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2004 | 670 | 0.010 |
Why?
|
Quality of Health Care | 2 | 2009 | 4360 | 0.010 |
Why?
|
ROC Curve | 2 | 1998 | 3568 | 0.010 |
Why?
|
Taxoids | 1 | 2003 | 669 | 0.010 |
Why?
|
Depression | 1 | 1999 | 8045 | 0.010 |
Why?
|
Health Surveys | 1 | 2009 | 4063 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1990 | 5496 | 0.010 |
Why?
|
Rats | 3 | 2002 | 23709 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2002 | 959 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2000 | 238 | 0.010 |
Why?
|
Child, Preschool | 2 | 2000 | 42056 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1999 | 228 | 0.010 |
Why?
|
Case-Control Studies | 3 | 2002 | 22052 | 0.010 |
Why?
|
Sex Characteristics | 1 | 1988 | 2629 | 0.010 |
Why?
|
Electrophysiology | 1 | 2001 | 1265 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10826 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2000 | 343 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1987 | 2203 | 0.010 |
Why?
|
Administration, Oral | 1 | 2006 | 4035 | 0.010 |
Why?
|
Urban Health | 1 | 2000 | 533 | 0.010 |
Why?
|
Remission Induction | 1 | 2003 | 2392 | 0.010 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 1996 | 19 | 0.010 |
Why?
|
Software | 1 | 2011 | 4419 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2005 | 1060 | 0.010 |
Why?
|
Ohio | 1 | 1997 | 333 | 0.010 |
Why?
|
Anxiety | 1 | 2011 | 4538 | 0.010 |
Why?
|
Oregon | 1 | 1996 | 148 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5201 | 0.010 |
Why?
|
United States Public Health Service | 1 | 1996 | 31 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2000 | 1849 | 0.010 |
Why?
|
Hospitalization | 1 | 1996 | 10789 | 0.010 |
Why?
|
Morbidity | 1 | 2001 | 1765 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1990 | 3075 | 0.010 |
Why?
|
Schizophrenia | 1 | 1995 | 6915 | 0.010 |
Why?
|
Marijuana Abuse | 1 | 2000 | 411 | 0.010 |
Why?
|
Cell Count | 1 | 2000 | 1835 | 0.010 |
Why?
|
Aging | 1 | 1995 | 8652 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5508 | 0.010 |
Why?
|
Survival Analysis | 2 | 1999 | 10185 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 1998 | 386 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 1987 | 3839 | 0.010 |
Why?
|
Fee-for-Service Plans | 1 | 2000 | 705 | 0.010 |
Why?
|
Rehabilitation, Vocational | 1 | 1995 | 81 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2003 | 4899 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2852 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1995 | 433 | 0.010 |
Why?
|
Reference Values | 1 | 2001 | 4925 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1995 | 865 | 0.010 |
Why?
|
Fetus | 1 | 2001 | 1859 | 0.010 |
Why?
|
Hospital Charges | 1 | 1996 | 359 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1994 | 168 | 0.010 |
Why?
|
Candida albicans | 1 | 1996 | 374 | 0.010 |
Why?
|
Spinal Cord | 1 | 2002 | 1817 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1999 | 1791 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1999 | 2569 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2005 | 3486 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 2235 | 0.010 |
Why?
|
Biomedical Research | 1 | 2008 | 3426 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1995 | 591 | 0.010 |
Why?
|
CHO Cells | 1 | 1995 | 1389 | 0.010 |
Why?
|
Pneumonectomy | 1 | 1999 | 1111 | 0.010 |
Why?
|
Length of Stay | 2 | 1996 | 6476 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 1999 | 14494 | 0.010 |
Why?
|
Cricetinae | 1 | 1995 | 2427 | 0.010 |
Why?
|
Fathers | 1 | 1994 | 376 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 5869 | 0.010 |
Why?
|
Antigens, CD | 1 | 2001 | 4000 | 0.010 |
Why?
|
Homeostasis | 1 | 2002 | 3306 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8158 | 0.010 |
Why?
|
Infection Control | 1 | 1998 | 983 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1997 | 1264 | 0.010 |
Why?
|
Interprofessional Relations | 1 | 1996 | 989 | 0.010 |
Why?
|
Social Environment | 1 | 1995 | 1022 | 0.010 |
Why?
|
Career Choice | 1 | 1996 | 754 | 0.010 |
Why?
|
HeLa Cells | 1 | 1995 | 3105 | 0.010 |
Why?
|
Palliative Care | 1 | 2004 | 3607 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1999 | 2628 | 0.000 |
Why?
|
Comorbidity | 1 | 2003 | 10553 | 0.000 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1995 | 800 | 0.000 |
Why?
|
Uterine Cervicitis | 1 | 1988 | 31 | 0.000 |
Why?
|
Arousal | 1 | 1994 | 1157 | 0.000 |
Why?
|
Microscopy, Fluorescence | 1 | 1995 | 2651 | 0.000 |
Why?
|
Insurance, Health | 1 | 2000 | 2501 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3465 | 0.000 |
Why?
|
Reaction Time | 1 | 1994 | 2075 | 0.000 |
Why?
|
Medicine | 1 | 1996 | 943 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6130 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1994 | 36286 | 0.000 |
Why?
|
Protamines | 1 | 1987 | 111 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2002 | 18955 | 0.000 |
Why?
|
Forecasting | 1 | 1996 | 2931 | 0.000 |
Why?
|
Apoptosis | 1 | 2002 | 9497 | 0.000 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1988 | 238 | 0.000 |
Why?
|
Liver | 1 | 2002 | 7510 | 0.000 |
Why?
|
Activities of Daily Living | 1 | 1995 | 2417 | 0.000 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1987 | 465 | 0.000 |
Why?
|
Cell Survival | 1 | 1995 | 5797 | 0.000 |
Why?
|
Bone Marrow | 1 | 1995 | 2914 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 6015 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1988 | 20509 | 0.000 |
Why?
|
Polysaccharides, Bacterial | 1 | 1987 | 574 | 0.000 |
Why?
|
Complement System Proteins | 1 | 1987 | 782 | 0.000 |
Why?
|
Phenotype | 1 | 2001 | 16548 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 2471 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 2526 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1996 | 3598 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1994 | 4716 | 0.000 |
Why?
|
Base Sequence | 1 | 1994 | 12444 | 0.000 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1995 | 2275 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2005 | 11345 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1987 | 1229 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 17624 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 1994 | 7022 | 0.000 |
Why?
|
Parity | 1 | 1984 | 925 | 0.000 |
Why?
|
Chronic Disease | 1 | 1995 | 9288 | 0.000 |
Why?
|
Antibodies | 1 | 1987 | 2421 | 0.000 |
Why?
|
Electroencephalography | 1 | 1994 | 6189 | 0.000 |
Why?
|
Family | 1 | 1988 | 3189 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1995 | 22020 | 0.000 |
Why?
|
Cognition | 1 | 1994 | 6964 | 0.000 |
Why?
|
Cell Line | 1 | 1987 | 15620 | 0.000 |
Why?
|
Mice | 1 | 1995 | 81209 | 0.000 |
Why?
|